359 related articles for article (PubMed ID: 29967607)
1. Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions.
Haspels HN; Rahman MA; Joseph JV; Gras Navarro A; Chekenya M
Front Immunol; 2018; 9():1345. PubMed ID: 29967607
[TBL] [Abstract][Full Text] [Related]
2. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
3. The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
Hens J; Jennes W; Kestens L
AIDS Res Ther; 2016; 13():15. PubMed ID: 26997965
[TBL] [Abstract][Full Text] [Related]
4. The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection.
Rajalingam R
Front Immunol; 2016; 7():585. PubMed ID: 28066408
[TBL] [Abstract][Full Text] [Related]
5. Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.
Zhang H; Cui Y; Voong N; Sabatino M; Stroncek DF; Morisot S; Civin CI; Wayne AS; Levine BL; Mackall CL
J Immunother; 2011 Mar; 34(2):187-95. PubMed ID: 21304401
[TBL] [Abstract][Full Text] [Related]
6. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
[TBL] [Abstract][Full Text] [Related]
7. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
8. Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion.
Wang W; Erbe AK; Alderson KA; Phillips E; Gallenberger M; Gan J; Campana D; Hank JA; Sondel PM
Cancer Immunol Immunother; 2016 Sep; 65(9):1047-59. PubMed ID: 27392940
[TBL] [Abstract][Full Text] [Related]
9. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
10. Impact of the Variable Killer Ig-Like Receptor-Human Leukocyte Antigen Interactions on Natural Killer Cell Cytotoxicity Toward Foreign CD4 T Cells.
Hens J; Goovaerts O; Ceulemans A; Jennes W; Kestens L
Front Immunol; 2018; 9():1588. PubMed ID: 30038628
[TBL] [Abstract][Full Text] [Related]
11. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Gooneratne SL; Center RJ; Kent SJ; Parsons MS
Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
[TBL] [Abstract][Full Text] [Related]
12. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
13. Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors.
Re F; Staudacher C; Zamai L; Vecchio V; Bregni M
Cancer; 2006 Aug; 107(3):640-8. PubMed ID: 16804934
[TBL] [Abstract][Full Text] [Related]
14. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
[TBL] [Abstract][Full Text] [Related]
15. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
16. Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand.
Oh SJ; Yang JI; Kim O; Ahn EJ; Kang WD; Lee JH; Moon KS; Lee KH; Cho D
Cancer Cell Int; 2017; 17():22. PubMed ID: 28203118
[TBL] [Abstract][Full Text] [Related]
17. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival.
Gras Navarro A; Espedal H; Joseph JV; Trachsel-Moncho L; Bahador M; Gjertsen BT; Kristoffersen EK; Simonsen A; Miletic H; Enger PØ; Rahman MA; Chekenya M
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31319548
[No Abstract] [Full Text] [Related]
19. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands.
Han M; Fallena M; Guo Y; Stastny P
Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
